||Achaogen is focused on the research and development of antibiotics for the treatment of serious multi-drug resistant (MDR) Gram-negative bacterial infections.
develops therapeutic proteins in oncology/hematopoiesis,
inflammation, and neurobiology/endocrinology.
||BioSurplus is focused on providing equipment management solutions and pre-owned scientific instruments to the life sciences industry.
||Catalyst Biosciences is focused on creating novel catalytic biopharmaceutical products based on engineered human proteases.
||Cato Research is a global is
a full-service contract research and development
||CoMentis is focused on the development of two technology platforms: (i) aspartic protease inhibitors and (ii) nicotinic acetylcholine receptor (nAChR) agonists and antagonists for the treatment of angiogenesis mediated or cognitive disorders.
is focused on the complementary missions of drug
discovery and the commercialization of novel cellular
||CytomX is focused on the research and development of monclonal antibody therapeutics.
is a company formed as a joint venture between
SmithKline Beecham Corp. and Incyte Pharmaceuticals,
Inc., dedicated to the discovery and commercialization
of novel molecular diagnostics.
is a rapidly growing, well-funded biopharmaceutical company whose mission is to
identify novel therapeutic targets for drug discovery
by elucidating the biochemical pathways involved
in human diseases.
|Five Prime Therapeutics
||Five Prime Therapeutics is focused on the discovery, research, and development of protein and antibody drugs.
||Fluidigm develops and distributes systems based on integrated fluidic circuits (IFCs).
Inc. is a leading biotechnology company using
human genetic information to develop, manufacture
and market biopharmaceuticals that address significant
unmet medical needs.
||Iconic Therapeutics is focused on therapeutic use of I-con1™ protein for the “wet” form of adult macular degeneration and many cancers.
||KaloBios is focused on the development of antibody therapeutics in autoimmunity, infectious disease, and cancer.
||MacroGenics is focused on the development and commercialization of biologics for the treatment of autoimmune disorders, cancer and infectious diseases.
||Monogram Biosciences is focused on the research, development, and commercialization of molecular diagnostics for infectious diseases, cancer and other serious diseases.
||NGM Biopharmaceuticals is focused on the development of treatments for metabolic diseases, such as obesity, muscle wasting and cardiovascular disease in addition to diabetes.
||Nodality is focused on utilizing advanced quantitative flow cytometry to enable clinical decision making for cancer treatment.
||Onyx Pharmaceuticals is focused on the research, development and commercialization of therapeutics for the treatment of cancer.
||OXiGENE is focused on the discovery and development of therapeutics for patients with cancer and sight-threatening eye diseases and conditions.
||Pfizer Inc. is involved in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide.
||Portola Pharmaceuticals is focused on developing therapeutics for the treatment of cardiovascular disease and inflammation.
employs a set of unique technologies in the rapid
discovery and validation of novel pharmaceutical
targets, as well as in the design of therapeutic
agents which regulate the function of these targets
in specific disease processes.
||Solazyme is focused on the development and commercialization of oils and bioproducts dervied from microalgae.
Pharmaceuticals is committed to becoming a leader
in the discovery of important new pharmaceutical
products for the treatment of human disease. They
are doing this by applying a revolutionary new
approach to drug discovery that is based on a
novel chemical methodology combined with critical
insights into the nature of molecular recognition
between natural macromolecules and their substrates
||Sutro Biopharma is focused on application of an Open Cell Free Synthesis (OCFS) technology which is an optimized E. coli extract for protein production.
||Theravance is focused on small molecule drugs across a number of therapeutic areas with an initial focus on respiratory disease, bacterial infections and gastrointestinal disorders.
||Threshold Pharmaceuticals is focused on small molecule drugs that take advantage of tumor hypoxia.
Pharmaceuticals develops products for the treatment
of cancer and central nervous system disorders.
||Trellis Bioscience is focused on monoclonal antibody therapeutics for infectious disease and oncology.